Jason T Dougherty

US Patent:

20170239468, Aug 24, 2017

Filed:

May 8, 2017

Appl. No.:

15/589754

Inventors:

John LEMKE - Pleasanton CA, US
Scot SATRE - Brentwood CA, US
Corinna X. CHEN - Oakland CA, US
Brian W. READ - Brier WA, US
Zita S. NETZEL - Los Altos CA, US
David SEWARD - Seattle WA, US
Bradley E. WHITE - Lebanon OH, US
Paul HAYTER - Mountain View CA, US
Jason E. DOUGHERTY - Seattle WA, US

International Classification:

A61N 1/32
A61K 31/4468
B29C 65/48
B29C 65/56
A61N 1/08
A61M 37/00

Abstract:

A switch-operated therapeutic agent delivery device. Embodiments of the operated therapeutic agent delivery device my include a switch that can be operated by a user, a device controller connected to the switch through a switch input where the device can actuate the device when certain predetermined conditions are met, following performance of both a digital switch validation test and an analog switch validation test. The switch operated therapeutic agent delivery device may have two parts, which are assembled by a user prior to use. These devices may be configured to determine if a current is present between the anode and cathode when drug is not intended to be delivered by the device. These devices may indirectly control and/or monitor the applied current without directly measuring from the cathode of the patient terminal.

US Patent:

20150196754, Jul 16, 2015

Filed:

Mar 5, 2013

Appl. No.:

14/406969

Inventors:

- Redwood City CA, US
- Vacaville CA, US
John Lemke - Pleasanton CA, US
Scot Satre - Brentwood CA, US
Corinna X. Chen - Oakland CA, US
Brian W. Read - Brier WA, US
Jason E. Dougherty - Seattle WA, US

Assignee:

ALZA CORPORATION - Vacaville CA
INCLINE THERAPEUTICS, INC. - Redwood City CA

International Classification:

A61N 1/32

Abstract:

Devices, systems and methods for controlling the application of current and/or voltage to deliver drug from patient contacts of an electrotransport drug delivery device by indirectly controlling and/or monitoring the applied current without directly measuring from the cathode of the patient terminal. In particular, described herein are electrotransport drug delivery systems including constant current delivery systems having a feedback current and/or voltage control module that is isolated from the patient contacts (e.g., anodes and cathodes). The feedback module may be isolated by a transistor from the patient contacts; feedback current and/or voltage control measurements may be performed at the transistor rather than at the patient contact (e.g., cathode).

US Patent:

20140288526, Sep 25, 2014

Filed:

Jun 4, 2014

Appl. No.:

14/296085

Inventors:

John LEMKE - Pleasanton CA, US
Scot SATRE - Brentwood CA, US
Corinna X. CHEN - Oakland CA, US
Brian W. READ - Brier WA, US
Jason E. Dougherty - Seattle WA, US
Nitin B. Joshi - Redwood City CA, US

International Classification:

A61M 5/168

US Classification:

604500, 604 65

Abstract:

A switch-operated therapeutic agent delivery device is described. Embodiments of the operated therapeutic agent delivery device include a switch that can be operated by a user, a device controller connected to the switch through a switch input where the device can actuate the device when certain predetermined conditions are met, following performance of both a digital switch validation test and an analog switch validation test.

Author:

Jason Dougherty

ISBN #:

0595277500